Why Is Telix Pharmaceuticals Stock Gaining Tuesday?

Telix Pharmaceuticals Limited (NASDAQ:TLX) shares are up during Tuesday’s premarket session following the announcement that Part 1 of the ProstACT Global Phase 3 study achieved its primary objectives. The study demonstrated an acceptable safety and tolerability...